Prof. Dr. Margitta Worm
VeröffentlichungenOriginalarbeiten 2015 – 2020
Originalarbeiten
A – Originalarbeiten 2015 – 2020
| 1. | Manger B1, Hiepe F2, Schneider M3, Worm M4, Wimmer P5, Paulus EM5, Schwarting A (2015). Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study. Clin Exp Gastroenterol. 21;8:205-13. |
| 2. | Tomsitz D; Stefaniak R; Worm M (2015). Rituximab in patients with recalcitrant autoimmune blistering diseases: experience in a cohort of 22 patients. (2014) Br J Dermatol. 172(3):829-31. |
| 3. | Dinkloh A; Worm M; Geier J; Schnuch A; Wollenberger A (2015) Contact sensitization in patients with suspected cosmetic intolerance: results of the IVDK 2006-2011. (2014) J Eur Acad Dermatol Venereol. 29(6):1071-81. |
| 4. | Moinzadeh P; Aberer E; Ahmadi-Simab K; Blank N; Distler JH; Fierlbeck G; Genth E; Guenther C; Hein R; Henes J; Herich L; Herrgott I; Koetter I; Kreuter A; Krieg T; Kuhr K; Lorenz HM; Meier F; Melchers I; Mensing H; Ladner U; Pfeiffer C; Riemekasten G; Sárdy M; Schmalzing M; Sunderkoetter C; Susok L; Tarner IH; Vaith P; Worm M; Wozel G; Zeidler G; Hunzelmann N; and all participating DNSS centers (2015). Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 74(4):730-7. |
| 5. | Kumari V; Babina M; Hazzan T; Worm M (2015). TSLP induction by skin irritation is independent of TNF-?, but supported by IL-1. (2014) Br J Dermatol. 172(4):951-60. |
| 6. | Klaus P; Heine G; Rasche C; Worm M (2015). Low-dose anti-thymocyte globulin inhibits human B-cell differentiation into antibody secreting cells. Acta Derm Venereol. 95:676-680. |
| 7. | Didier A; Malling HJ; Worm M; Horak F; Sussman GL (2015). Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score. Clin Transl Allergy. 22;5:12. |
| 8. | Rübsam A; Stefaniak R; Worm M; Pleyer U (2015). Rituximab preserves vision in ocular mucous membrane pemphigoid. Expert Opin Biol Ther. 15(7):927-33. |
| 9. | Mascarell L; Rak S; M Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P (2015). Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells. Allergy. 70(4):408-19. |
| 10. | Dölle S; Hielscher N; Bareille PJ; Hardes K; Robertson J; Worm M (2015). Clinical efficacy and tolerability of a novel selective corticosteroid in atopic dermatitis–two randomised controlled trials. Skin Pharmacol Physiol. 28(3):159-66. |
| 11. | Nassiri M; Babina M; Dölle S; Edenharter G; Ruëff F; Worm M (2015). Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming. J Allergy Clin Immunol. 135(2):491-9. |
| 12. | Brockow K; Schallmayer S; Beyer K; Biedermann T; Fischer J; Gebert N; Grosber M; Jakob T; Klimek L; Kugler C; Lange L; Pfaar O; Przybilla B; Rietschel E; Rueff F; Schnadt S; Szczepanski R; Worm M; Kupfer J; Gieler U; Ring J; working group on anaphylaxis training and education (AGATE) (2015). |
| 13. | Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy. 70(2):227-35. |
| 14. | Glatz M; Buchner M; von Bartenwerffer W; Schmid-Grendelmeier P; Worm M; Hedderich J; Fölster-Holst R (2015). Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults. Acta Derm Venereol. 95(2):191-6. |
| 15. | Worm M; Lippert U; Geier J; Schnuch A (2015). Kontaktallergien im Kindesalter. Hautarzt. 66:646–651. |
| 16. | Francuzik W; Nassiri M; Babina M; Worm M (2015). Impact of sex on anaphylaxis severity–data from the Anaphylaxis Registry. J Allergy Clin Immunol. Nov;136(5):1425-6. |
| 17. | Thaçi D; Simpson EL; Beck LA; Bieber T; Blauvelt A; Papp K; Soong W; Worm M; Szepietowski JC; Sofen H; Kawashima M; Wu R; Weinstein SP; Graham NM; Pirozzi G; Teper A; Sutherland ER; Mastey V; Stahl N; Yancopoulos GD; Ardeleanu M (2016). Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet. Jan 2;387(10013):40-52. |
| 18. | Grabenhenrich LB; Dölle S; Moneret-Vautrin A; Köhli A; Lange L; Spindler T; Ruëff F; Nemat K; Maris I; Roumpedaki E; Scherer K; Ott H; Reese T; Mustakov T; Lang R; Fernandez-Rivas M; Kowalski ML; Bilò MB; Hourihane JO; Papadopoulos NG; Beyer K; Muraro A; Worm M (2016). Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. Apr;137(4):1128-1137. |
| 19. | Hallau J; Hamann L; Schumann RR; Worm M; Heine G (2016). A Promoter Polymorphism of the Vitamin D Metabolism Gene Cyp24a1 is Associated with Severe Atopic Dermatitis in Adults. Acta Derm Venereol. Feb;96(2):169-72. |
| 20. | Mudnakudu Nagaraju KK; Babina M; Weise C; Kühl A; Schulzke J; Worm M (2016). Bortezomib treatment diminishes hazelnut-induced intestinal anaphylaxis in mice. Eur J Immunol. Jul;46(7):1727-36. |
| 21. | Simpson EL; Gadkari A; Worm M; Soong W; Blauvelt A; Eckert L; Wu R; Ardeleanu M; Graham NM; Pirozzi G; Sutherland E; Mastey V (2016). Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). J Am Acad Dermatol. Sep;75(3):506-15. |
| 22. | Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C (2016). Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. J Allergy Clin Immunol. Jul;138(1):162-8. |
| 23. | Worm M; Grünhagen J; Dölle S (2016). Food-induced anaphylaxis – data from the anaphylaxis registry. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Jul;59(7):836-40. |
| 24. | Kumari V; Timm K; Kühl AA; Heine G; Worm M (2016). Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema. Br J Dermatol. Dec;175(6):1243-1250. |
| 25. | Nassiri M; Eckermann O; Babina M; Edenharter G, Worm M (2016). Serum levels of 9?,11?-PGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis. J Allergy Clin Immunol. Jan;137(1):312-4. |
| 26. | Hunzelmann N; Riemekasten G; Becker MO; Moinzadeh P; Kreuter A; Melchers I; Mueller-Ladner U; Meier F; Worm M; Lee H; Herrgott I; Pfeiffer C; Fierlbeck G; Henes J; Juche A; Zeidler G; Mensing H; Günther C; Sárdy M; Burkhardt H; Koehm M; Kuhr K; Krieg T; Sunderkötter C (2016).The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies. Br J Dermatol. Jun;174(6):1384-7. |
| 27. | Moinzadeh P; Riemekasten G; Siegert E; Fierlbeck G; Henes J; Blank N; Melchers I; Mueller-Ladner U; Frerix M; Kreuter A; Tigges C; Lahner N; Susok L; Guenther C; Zeidler G; Pfeiffer C; Worm M; Karrer S; Aberer E; Bretterklieber A; Genth E; Simon JC; Distler JH; Hein R; Schneider M; Seitz CS; Herink C; Steinbrink K; Sárdy M; Varga R; Mensing H; Mensing C; Lehmann P; Neeck G; Fiehn C; Weber M; Goebeler M; Burkhardt H; Buslau M; Ahmadi-Simab K; Himsel A; Juche A; Koetter I; Kuhn A; Sticherling M; Hellmich M; Kuhr K; Krieg T; Ehrchen J; Sunderkoetter C; Hunzelmann N; German Network for Systemic Scleroderma (2016). Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients. J Rheumatol. 2016 Jan;43(1):66-74. |
| 28. | Simpson EL; Bieber T; Guttman-Yassky E; Beck LA; Blauvelt A; Cork MJ; Silverberg JI; Deleuran M; Kataoka Y; Lacour JP; Kingo K; Worm M; Poulin Y; Wollenberg A; Soo Y; Graham NM; Pirozzi G; Akinlade B; Staudinger H; Mastey V; Eckert L; Gadkari A; Stahl N; Yancopoulos GD; Ardeleanu M; SOLO 1 and SOLO 2 Investigators (2016). Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. Sep 30. [Epub ahead of print] |
| 29. | Bacher P; Heinrich F; Stervbo U; Nienen M; Vahldieck M; Iwert C; Vogt K; Kollet J5 Babel N; Sawitzki B; Schwarz C; Bereswill S; Heimesaat MM; Heine G; Gadermaier G; Asam C; Assenmacher M; Kniemeyer O; Brakhage AA; Ferreira F; Wallner M; Worm M; Scheffold A (2016). Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans. Cell. Nov 3;167(4):1067-1078.e16. |
| 30. | Hahn-Pedersen J; Worm M; Green W; Andreasen JN; Taylor M (2016).Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting. Clin Transl Allergy. Sep 7;6(1):35. |
| 31. | Ahrens HC; Siegert E; Tomsitz D; Mattat K; March C; Worm M; Riemekasten G (2016). Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis. Clin Exp Rheumatol. Sep-Oct;34 Suppl 100(5):142-147. |
| 32. | Werfel T; Aberer W; Ahrens F; Augustin M; Biedermann T; Diepgen T; Fölster-Holst R; Gieler U; Heratizadeh A; Kahle J; Kapp A; Nast A; Nemat K; Ott H; Przybilla B; Roecken M; Schlaeger M; Schmid-Grendelmeier P; Schmitt J; Schwennesen T; Staab D; Worm M; Association of Scientific Medical Societies of Germany (2016). Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis]. J Dtsch Dermatol Ges. Jan;14(1):e1-75 |
| 33. | Lötzsch B, Dölle S, Vieths S, Worm M (2016).Exploratory analysis of CD63 and CD203c expression in basophils from hazelnut sensitized and allergic individuals. Clin Transl Allergy. Dec 13;6:45. |
| 34. | Calderon M.A; Demoly P; Casale T., Akdis C.A; Bachert C; Bewick M; Bilò B.M; Bohle B; Bonini S; Bush A; Caimmi D.P; Canonica G.W; Cardona V; Chiriac A.M; Cox L; Custovic A; De Blay F; Devillier P; Didier A; Di Lorenzo G; Du Toit G; Durham S.R; Eng P; Fiocchi A; Fox A.T; van Wijk R.G; Gomez R.M; Haathela T; Halken S; Hellings P.W; Jacobsen L; Just J; Tanno L.K; Kleine-Tebbe J; Klimek L; Knol E.F; Kuna P; Larenas-Linnemann D.E; Linneberg A; Matricardi M; Malling H.J; Moesges R; Mullol J; Muraro A; Papadopoulos N; Passalacqua G; Pastorello E; Pfaar O; Price D; Del Rio P.R; Ruëff R; Samolinski B; Scadding G.K; Senti G., Shamji M.H; Sheikh A; Sisul J.C; Sole D; Sturm G.J; Tabar A; Van Ree R; Ventura M.T; Vidal C; Varga E.M; Worm M; Zuberbier T. and Bousquet J (2016). Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clin Transl Allergy. 6:41. |
| 35. | Dhami S; Nurmatov U; Roberts G; Pfaar O; Muraro A., Ansotegui I.J; Calderon M; Cingi C; Demoly P; Durham S; van Wijk R.G; Halken S; Hamelmann E; Hellings P; Jacobsen L; Knol E; Linnemann D.L; Lin S; Maggina V; Oude-Elberink H; Pajno G; Panwankar R; Pastorello E; Pitsios C; Rotiroti G; Timmermans F; Tsilochristou O; Varga E.M; Wilkinson J; Williams A; Worm M; Zhang L. and Sheikh A (2016). Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review. Clin Transl Allergy. 6:12. |
| 36. | Klimek L; Pfaar O; Worm M (2016). New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs). Expert Rev Clin Immunol. 12(10):1123-35. |
| 37. | Kreuter A; Krieg T; Worm M; Wenzel J; Moinzadeh P; Kuhn A; Aberer E; Scharffetter-Kochanek K; Horneff G; Reil E; Weberschock T; Hunzelmann N (2016). German guidelines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges. 14(2):199-216. |
| 38. | Sölle A; Worm M; Flor H; Klinger R (2016). [Placebo response – Mechanisms and clinical applications]. Schmerz. 30(5):386-394. |
| 39. | Sunderkötter C; Nast A; Worm M; Dengler R; Dörner T; Ganter H; Hohlfeld R; Melms A; Melzer N; Rösler K; Schmidt J; Sinnreich M; Walter M.C; Wanschitz J; Wiendl H (2016). Guidelines on dermatomyositis–excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. J Dtsch Dermatol Ges. 14(3):321-38. |
| 40. | Treudler R; Franke A; Schmiedeknecht A; Ballmer-Weber B.K; Worm M; Werfel T; Jappe U; Biedermann T; Schmitt J; Brehler R; Kleinheinz A; Kleine-Tebbe J; Brüning H; Ruëff F; Ring J; Saloga J; Schäkel K; Holzhauser T; Vieths S; Simon J.C (2016). Standardization of double blind placebo controlled food challenge with soy within a multicentre trial. Clin Transl Allergy. 6:39. |
| 41. | Turner P.J; Baumert J.L; Beyer K; Boyle R.J; Chan C.H; Clark A.T; Crevel R.W.R; DunnGalvin A; Fernández-Rivas M; Gowland M.H; Grabenhenrich L; Hardy S; Houben G.F; O’B Hourihane J; Muraro A; Poulsen L.K; Pyrz K; Remington B.C; Schnadt S; van Ree R; Venter C; Worm M; Mills E.N.C; Roberts G; Ballmer-Weber B.K (2016). Can we identify patients at risk of life-threatening allergic reactions to food? Allergy. 71(9):1241-55. |
| 42. | Werfel T; Heratizadeh A; Aberer W; Ahrens F; Augustin M; Biedermann T; Diepgen T; Fölster-Holst R; Gieler U; Kahle J; Kapp A; Nast A; Nemat K; Ott H; Przybilla B; Roecken M; Schlaeger M; Schmid-Grendelmeier P; Schmitt J; Schwennesen T; Staab D; Worm M (2016). S2k guideline on diagnosis and treatment of atopic dermatitis–short version. J Dtsch Dermatol Ges. 14(1):92-106. |
| 43. | Westphal G.A; Rihs H.P; Schaffranek A; Zeiler T; Werfel T; Heratizadeh A; Dickel H; Weisshaar E; Bauer A; Schliemann S; Reich K; Breuer K; Schröder-Kraft C; Worm M; Molin S; Brans R; Schäkel K; Schwantes H; Pföhler C; Szliska C; Kreft B; Löffler H; Bünger J; Brüning T; Geier J; Schnuch A (2016). A variant of the CXCL11 gene may influence susceptibility to contact allergy, particularly in polysensitized patients. Contact Dermatitis. 75(5):303-307. |
| 44. | Worm M; Vieths S (2016). [Editorial of the special issue Food allergy and other food intolerances : part 2]. Bundesgesundheitsblatt. 59(7):819-20. |
| 45. | Worm M; Vieths S (2016). [Editorial of the special issue on food allergies and other food intolerances]. Bundesgesundheitsblatt. 2016;59(6):703-4. |
| 46. | Wylon K; Dölle S; Worm M (2016). Polyethylene glycol as a cause of anaphylaxis. Allergy Asthma Clin Immunol. 12:67. |
| 47. | Kraft M; Worm M (2017). Dupilumab in the treatment of moderate-to-severe atopic dermatitis. Expert Rev Clin Immunol. Apr;13(4):301-310. |
| 48. | Worm M; Ernst ; Kraller M; Babina M (2017). The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent. Int Arch Allergy Immunol. 172(1):20-26. |
| 49. | Dhami S; Sheikh A; Muraro A; Roberts G; Halken S; Fernandez Rivas M; Worm M; Sheikh A (2017). Quality indicators for the acute and long-term management of anaphylaxis: a systematic review. Clin Transl Allergy. 7:15. |
| 50. | Muraro A; Lemanske R.F; Castells M; Torres M.J; Khan D; Simon H.U; Bindslev-Jensen C; Burks W; Poulsen L.K; Sampson H.A; Worm M; Nadeau K.C (2017). Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy. 72(7):1006-1021. |
| 51. | Nurmatov U; Dhami S; Arasi S; Roberts G; Pfaar O; Muraro A; Ansotegui I.J; Calderon M; Cingi C; Durham S; van Wijk R.G; Halken S; Hamelmann E; Hellings P; Jacobsen L; Knol E; Larenas-Linnemann D; Lin S.Y; Maggina V; Oude-Elberink H; Pajno G; Panwankar R; Pastorello E; Pitsios C; Rotiroti G; Timmermans F; Tsilochristou O; Varga E.M; Wilkinson J; Williams A; Worm M; Zhang L; Sheikh A (2017). Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy. 7:24. |
| 52. | Reese I; Ballmer-Weber B; Beyer K; Fuchs T; Kleine-Tebbe J; Klimek L; Lepp U; Niggemann B; Saloga J; Schäfer C; Werfel T; Zuberbier T; Worm M (2017). German guideline for the management of adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Association of Allergologists (AeDA), and the Swiss Society for Allergology and Immunology (SGAI). Allergo J Int. 26(2):72-79. |
| 53. | Sánchez-Borges M; Cardona V; Worm M; Lockey R.F; Sheikh A; Greenberger P.A; Ansotegui I.J; Ebisawa M; El-Gamal Y; Fineman S; Geller M; Gonzalez-Estrada A; Tanno L; Thong B.Y; WAO Anaphylaxis Committee (2017). In-flight allergic emergencies. World Allergy Organ J. 10(1):15. |
| 54. | Treudler R; Franke A; Schmiedeknecht A; Ballmer-Weber B; Worm M; Werfel T; Jappe U; Biedermann T; Schmitt J; Brehler R; Kleinheinz A; Kleine-Tebbe J; Brüning H; Ruëff F; Ring J; Saloga J; Schäkel K; Holzhauser T; Vieths S; Simon J.C (2017). BASALIT trial: double-blind placebo-controlled allergen immunotherapy with rBet v 1-FV in birch-related soya allergy. Allergy. 72(8):1243-1253. |
| 55. | Wylon K; Drozdenko G; Krannich A; Heine G; Dölle S; Worm M (2017). Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol. PLoS ONE. 2017;12(1):e0169620. |
| 56. | Klimek L; Sperl A; Worm M; Ring J (2017). [Anaphylaxis – Causes, therapy and prevention]. MMW Fortschr Med. Nov;159(Suppl 3):76-84. |
| 57. | Hazzan T; Guhl S; Artuc M; Franke K; Worm M; Zuberbier T; Babina M (2017). An efficient method for gene knock-down by RNA interference in human skin mast cells. Exp Dermatol. Nov;26(11):1136-1139. |
| 58. | Ruzicka T; Hanifin JM; Furue M; Pulka G; Mlynarczyk I; Wollenberg A; Galus R; Etoh T; Mihara R; Yoshida H; Stewart J; Kabashima K1; XCIMA Study Group (2017). Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis. N Engl J Med. Mar 2;376(9):826-835. |
| 59. | Hazzan T; Eberle J; Worm M; Babina M (2017). Apoptotic resistance of human skin mast cells is mediated by Mcl-1. Cell Death Discov. Aug 21;3:17048. |
| 60. | Schnuch A; Müller BP; Geier J; Departments of Dermatology (2017). Differences in contents of organochlorine impurities do not influence responses to patch testing with Majantol®. Contact Dermatitis. Jan;76(1):11-18. |
| 61. | Pfaar O; Hohlfeld JM; Al-Kadah B; Hauswald B; Homey B; Hunzelmann N; Schliemann S; Velling P; Worm M; Klimek L (2017). Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid. Clin Exp Allergy. Nov;47(11):1445-1455. |
| 62. | Heratizadeh A; Werfel T; Wollenberg A; Abraham S; Plank-Habibi S; Schnopp C; Sticherling M; Apfelbacher C; Biedermann T; Breuer K; Fell I; Fölster-Holst R; Heine G; Grimm J; Hennighausen L; Kugler C; Reese I; Ring J; Schäkel K Schmitt J; Seikowski K; von Stebut E; Wagner N; Waßmann-Otto A; Wienke-Graul U; Weisshaar E; Worm M; Gieler U; Kupfer J; Arbeitsgemeinschaft Neurodermitisschulung für Erwachsene (ARNE) Study Group (2017). Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial. J Allergy Clin Immunol. Sep;140(3):845-853.e3. |
| 63. | Clowse ME; Wallace DJ; Furie RA; Petri MA; Pike MC; Leszczy?ski P; Neuwelt CM; Hobbs K; Keiserman M; Duca L; Kalunian KC; Galateanu C; Bongardt S; Stach C; Beaudot C; Kilgallen B; Gordon C; EMBODY Investigator Group (2017). Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis Rheumatol. Feb;69(2):362-375. |
| 64. | Lindner J; Rausch S; Treptow S; Geldmeyer-Hilt K; Krause T; St-Arnaud R; Arabian A; Radbruch A; Hartmann S; Worm M; Heine G (2017). Endogenous Calcitriol Synthesis Controls the Humoral IgE Response in Mice. J Immunol. Dec 15;199(12):3952-3958. |
| 65. | Dhami S; Nurmatov U; Roberts G; Pfaar O; Muraro A; Ansotegui IJ; Calderon M; Cingi C; Demoly P; Durham S; van Wijk RG; Halken S; Hamelmann E; Hellings P; Jacobsen L; Knol E; Linnemann DL; Lin S; Maggina V; Oude-Elberink H; Pajno G; Panwankar R; Pastorello E; Pitsios C; Rotiroti G; Timmermans F; Tsilochristou O; Varga EM; Wilkinson J; Williams A; Worm M; Zhang L; Sheikh A (2017). Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review. Clin Transl Allergy. Sep 15;7:29. |
| 66. | Knobler R; Moinzadeh P; Hunzelmann N; Kreuter A; Cozzio A; Mouthon L; Cutolo M; Rongioletti F; Denton CP; Rudnicka L; Frasin LA; Smith V; Gabrielli A; Aberer E; Bagot M; Bali G; Bouaziz J; Braae Olesen A; Foeldvari I; Frances C; Jalili A; Just U; Kähäri V; Kárpáti S; Kofoed K; Krasowska D; Olszewska M; Orteu C; Panelius J; Parodi A; Petit A; Quaglino P; Ranki A; Sanchez Schmidt JM; Seneschal J; Skrok A; Sticherling M; Sunderkötter C;, Taieb A; Tanew A; Wolf P; Worm M; Wutte NJ; Krieg T (2017). European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol. Sep;31(9):1401-1424. |
| 67. | Knobler R; Moinzadeh P; Hunzelmann N; Kreuter A; Cozzio A; Mouthon L; Cutolo M; Rongioletti F; Denton CP; Rudnicka L; Frasin LA; Smith V; Gabrielli A; Aberer E; Bagot M; Bali G; Bouaziz J; Braae Olesen A; Foeldvari I; Frances C; Jalili A; Just U; Kähäri V; Kárpáti S; Kofoed K; Krasowska D; Olszewska M; Orteu C; Panelius J; Parodi A; Petit A; Quaglino P; Ranki A; Sanchez Schmidt JM; Seneschal J; Skrok A; Sticherling M; Sunderkötter C;, Taieb A; Tanew A; Wolf P; Worm M; Wutte NJ; Krieg T (2017). European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1581-1594. |
| 68. | Sadik CD; Bischof J; van Beek N; Dieterich A; Benoit S; Sárdy M; Worm M; Meller S; Gläser R; Zillikens D; Homey B; Setterfield J; Minassian D; Schmidt E; Dart J; MMP study group 2009 – 2014; Autoimmune Bullous Diseases Study Group; Ibrahim SM (2017). Genomewide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid. Exp Dermatol. Dec;26(12):1214-1220. |
| 69. | Uter W; Lessmann H; Geier J; IVDK (2017). Is octocrylene a frequent contact allergen? Contact Dermatitis. Aug;77(2):127-128. |
| 70. | Worm M; Sturm G; Kleine-Tebbe J; Cichocka-Jarosz E; Cardona V; Maris I; Dölle S (2017). New trends in anaphylaxis. Allergo J Int. 26(8):295-300. |
| 71. | Wittenberg M; Nassiri M; Francuzik W; Lehmann K; Babina M; Worm M (2017). Serum levels of 9?,11?-PGF2 and apolipoprotein A1 achieve high predictive power as biomarkers of anaphylaxis. Allergy. Nov;72(11):1801-1805. |
| 72. | Worm M; Kirschbaum F; von der Emde G (2017). Social interactions between live and artificial weakly electric fish: Electrocommunication and locomotor behavior of Mormyrus rume proboscirostris towards a mobile dummy fish. PLoS One. Sep 13;12(9):e0184622. |
| 73. | Worm M; Scherer K; Köhli-Wiesner A; Ruëff F; Mahler V; Lange L; Treudler R; Rietschel E; Szepfalusi Z; Lang R; Rabe U; Reese T; Schwerk N; Beyer K; Hompes S; Bircher A; Przybilla B; Hawranek T; Hansen G; Friedrichs F; Merk H; Tenbrock K; Lehmann S; Gerstlauer M; Kleine-Tebbe J; Niggemann B; Dickel H; Bücheler M; Bieber T; Hanfland J; Schmitt-Grohe S; Vlajnic D; Heckmann V; Nemat K; Schäkel K; Nordwig A; Schuster A; Schweitzer-Krantz S; Hillen U; Kopp M; Szliska C; Klinge J; Neustädter I; Fuchs T; Bruns R; Marsch C; Kreft B; Coors E; Rebien W; Wedi B; Pföhler C; Rett M; Henzgen M; Vöhringer P; Fölster-Holst R; Hunzelmann N; Siebenhaar G; Nestoris S; Schirpke C; Grabbe J; Stichtenoth G; Ring J; Brockow K; Brehler R; Yildiz I; Volkmuth S; Geißler M; Polz M; Riffelmann F; Thies S; Lepp U; Rabe U; Rebmann H; Spindler T; Klimek L; Pfaar O; Brosi W; Aberer W; Varga E; Reider N; Huttegger I; Kinaciyan T; Hoffmann-Sommergruber K; Eng P; Helbling A; Eigenmann P; Guggenheim R; Schmid-Grendelmeier P (2017). Food-induced anaphylaxis and cofactors – data from the anaphylaxis registry. Allergol Select. 2017 Aug 4;1(1):21-27. |
| 74. | Hohenadel M; Beyer K; Hompes S; Worm M1 (2017). Elicitors of severe allergic reactions – reports from allergists and emergency doctors. Allergol Select. 2017 Aug 4;1(1):14-20. |
| 75. | Breuer K; Worm M; Skudlik C; John SM (2017). Ethylene oxide as an occupational contact allergen – an underestimated problem? Allergol Select. 2017 Aug 4;1(1):9-13. |
| 76. | Heratizadeh A; Werfel T; Schubert S; Geier J; IVDK (2018). Contact sensitization in dental technicians with occupational contact dermatitis. Data of the Information Network of Departments of Dermatology (IVDK) 2001-2015. Contact Dermatitis. Apr;78(4):266-273. |
| 77. | Tanno LK; Bierrenbach AL; Simons FER; Cardona V; Thong BY; Molinari N; Calderon MA; Worm M; Chang YS; Papadopoulos NG; Casale T; Demoly P; on behalf the Joint Allergy Academies (2018). Critical view of anaphylaxis epidemiology: open questions and new perspectives. Allergy Asthma Clin Immunol. Apr 4;14:12. |
| 78. | Roberts G; Pfaar O; Akdis CA; Ansotegui IJ; Durham SR; Gerth van Wijk R; Halken S; Larenas-Linnemann D; Pawankar R; Pitsios C; Sheikh A; Worm M; Arasi S; Calderon MA; Cingi C; Dhami S; Fauquert JL; Hamelmann E; Hellings P; Jacobsen L; Knol EF; Lin SY; Maggina P; Mösges R; Oude Elberink JNG; Pajno GB; Pastorello EA; Penagos M; Rotiroti G; Schmidt-Weber CB; Timmermans F; Tsilochristou O; Varga EM; Wilkinson JN; Williams A; Zhang L; Agache I; Angier E; Fernandez-Rivas M; Jutel M; Lau S; van Ree R; Ryan D; Sturm GJ; Muraro A (2018). EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. Apr;73(4):765-798. |
| 79. | Grabenhenrich LB; Dölle S; Ruëff F; Renaudin JM; Scherer K; Pföhler C; Treudler R; Koehli A; Mahler V; Spindler T; Lange L; Bilò MB; Papadopoulos NG; Hourihane JOB; Lang R; Fernández-Rivas M; Christoff G; Cichocka-Jarosz E; Worm M (2018). Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register. J Allergy Clin Immunol Pract. Mar 29. |
| 80. | Worm M; Francuzik W; Renaudin JM; Bilo MB; Cardona V; Scherer Hofmeier K; Köhli A; Bauer A; Christoff G; Cichocka-Jarosz E; Hawranek T; Hourihane JO; Lange L; Mahler V; Muraro A; Papadopoulos NG; Pföhler C; Poziomkowska-G?sicka I; Ruëff F; Spindler T; Treudler R; Fernandez-Rivas M; Dölle S (2018). Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry. Allergy. Jun;73(6):1322-1330. |
| 81. | Jappe U; Minge S; Kreft B; Ludwig A; Przybilla B; Walker A; Varga R; Seidel P; Biedermann T; Anemüller W; Kromminga A; Ruëff F; Merk H; Wagner N; Treudler R; Worm M; Waldmann I; Saloga J; Becker WM; Goldmann T; Platts-Mills TA; Homann A (2018). Meat allergy associated with galactosyl-?-(1,3)-galactose (?-Gal)-Closing diagnostic gaps by anti-?-Gal IgE immune profiling. Allergy. Jan;73(1):93-105. |
| 82. | Schocker F; Recke A; Kull S; Worm M; Jappe U (2018). Persistent cow’s milk anaphylaxis from early childhood monitored by IgE and BAT to cow’s and human milk under therapy. Pediatr Allergy Immunol. Mar;29(2):210-214. |
| 83. | Francuzik W; Franke K; Schumann RR; Heine G; Worm M (2018). Propionibacterium acnes Abundance Correlates Inversely with Staphylococcus aureus: Data from Atopic Dermatitis Skin Microbiome. Acta Derm Venereol. Apr 27;98(5):490-495. |
| 84. | Schocker F; Recke A; Kull S; Worm M; Behrends J; Jappe U (2018). Reply to Chirumbolo et al. Pediatr Allergy Immunol. Jun;29(4):461-462. |
| 85. | Francuzik W; Dölle S; Worm M (2018). Risk factors and treatment of refractory anaphylaxis – a review of case reports. Expert Rev Clin Immunol. Apr;14(4):307-314. |
| 86. | Heine G; Hollstein T; Treptow S; Radbruch A; Worm M.(2018). 9-cis retinoic acid modulates the type I allergic immune response. J Allergy Clin Immunol. Feb;141(2):650-658.e5. |
| 87. | Haufe E; Abraham S; Heratizadeh A; Harder I; Zink A; Weisshaar E; Kleinheinz A; von Kiedrowski R; Worm M; Bell M; Wollenberg A; Neubert K; Staubach-Renz P; Hilgers M; Bieber T; Fell I; Homey B; Effendy I; Mempel M; Schäkel K; Beissert S; Weidinger S; Werfel T; Schmitt J (2018). [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema: Results from the German atopic eczema registry TREATgermany]. Hautarzt. Oct;69(10):815-824. |
| 88. | Grabowski J; Sehouli J; Glajzer J; Worm M; Zuberbier T; Fluhr J (2018). Olaparib Desensitization in a Patient with Recurrent Peritoneal Cancer. N Engl J Med. Nov 29;379(22):2176-2177. |
| 89. | Kettner A; DellaCorte G; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Simonsen K; Reymond C; Spertini F (2018). Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season. J Allergy Clin Immunol. Aug;142(2):678-680.e7. |
| 90. | Kraft M; Worm M (2018). Pemphigus Foliaceus-Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report. Front Med (Lausanne). Nov 9;5:315 |
| 91. | Muraro A; Fernandez-Rivas M; Beyer K; Cardona V; Clark A; Eller E; Hourihane JO; Jutel M; Sheikh A; Agache I; Allen KJ; Angier E; Ballmer-Weber B; Bilò MB; Bindslev-Jensen C; Camargo CA Jr; Cianferoni A; DunnGalvin A; Eigenmann PA; Halken S; Hoffmann-Sommergruber K; Lau S; Nilsson C; Poulsen LK; Rueff F; Spergel J; Sturm G; Timmermans F; Torres MJ; Turner P; van Ree R; Wickman M; Worm M; Mills ENC; Roberts G (2018). The urgent need for a harmonized severity scoring system for acute allergic reactions. Allergy. Sep;73(9):1792-1800. |
| 92. | Niederberger V; Neubauer A; Gevaert P; Zidarn M; Worm M; Aberer W; Malling HJ; Pfaar O; Klimek L; Pfützner W; Ring J; Darsow U; Novak N; Gerth van Wijk R; Eckl-Dorna J; Focke-Tejkl M; Weber M; Müller HH; Klinger J; Stolz F; Breit N; Henning R; Valenta R (2018). Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. J Allergy Clin Immunol. Aug;142(2):497-509.e9. |
| 93. | Pouessel G; Turner PJ; Worm M; Cardona V; Deschildre A; Beaudouin E; Renaudin JM; Demoly P; Tanno LK (2018). Food-induced fatal anaphylaxis: From epidemiological data to general prevention strategies. Clin Exp Allergy. Dec;48(12):1584-1593. |
| 94. | Recke A; Konitzer S; Lemcke S; Freitag M; Sommer NM; Abdelhady M; Amoli MM; Benoit S; El-Chennawy F; Eldarouti M; Eming R; Gläser R; Günther C; Hadaschik E; Homey B; Lieb W; Peitsch WK; Pföhler C; Robati RM; Saeedi M; Sárdy M; Sticherling M; Uzun S; Worm M; Zillikens D; Ibrahim S; Vidarsson G; Schmidt E; German AIBD Genetic Study Group (2018). The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts. Front Immunol. Aug 2;9:1788. |
| 95. | Reese I; Schäfer C; Kleine-Tebbe J; Ahrens B; Bachmann O; Ballmer-Weber B; Beyer K; Bischoff SC; Blümchen K; Dölle S; Enck P; Enninger A; Huttegger I; Lämmel S; Lange L; Lepp U; Mahler V; Mönnikes H; Ockenga J; Otto B; Schnadt S; Szepfalusi Z; Treudler R; Wassmann-Otto A; Zuberbier T; Werfel T; Worm M (2018). Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI). Allergo J Int. -151. |
| 96. | Ring J; Klimek L; Worm M (2018). Adrenaline in the Acute Treatment of Anaphylaxis. Dtsch Arztebl Int. Aug 6;115(31-32):528-534. |
| 97. | Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F; EURAP Study Group (2018). Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. Jun;17(6):530-538. |
| 98. | Worm M; Molaie N; Dölle S (2018). Level of knowledge among pharmacists regarding anaphylaxis and the use of epinephrine autoinjectors. J Dtsch Dermatol Ges. Nov;16(11):1315-1321. |
| 99. | Worm M; Higenbottam T; Pfaar O; Mösges R; Aberer W; Gunawardena K; Wessiepe D; Lee D; Kramer MF; Skinner M; Lees B; Zielen S (2018). Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy. Allergy. Sep;73(9):1812-1822. |
| 100. | Dölle S; Welter S; Ruppel E; Lehmann K; Schwarz D; Jensen-Jarolim E; Zieglmayer P; Franken P; Worm M (2018). Clinical reactivity of celery cultivars in allergic patients: Role of Api g 1. Clin Exp Allergy. 2018 Apr;48(4):424-432. |
| 101. | Worm M; Molaie N; Dölle S (2018). Wissensstand zur Anaphylaxie und Umgang mit Adrenalinautoinjektoren in Apotheken. J Dtsch Dermatol Ges. 16(11):1315-22. |
| 102. | Worm M; Heine G.; Radbruch A (2018). Immunomodulation by Vitamin D. Allergol Select. 2018; 2(1): 62–66. |
| 103. | Aurich S;, Dölle-Bierke S; Francuzik W; Bilo M.B; Christoff G; Fernandez-Rivas M; Hawranek T; Pföhler C; Poziomkowska-G?sicka I; Renaudin J.M; Oppel E; Scherer K; Treudler R; Worm M (2019). Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry. Front Immunol. 10:750. |
| 104. | Kraft M; Schubert S; Geier J; Worm M; IVDK (2019). Contact dermatitis and sensitization in professional musicians. Contact Dermatitis. 80(5):273-8. |
| 105. | Bauer A; Geier J; Schreiber S; Schubert S; IVDK (2019). Contact sensitization to plants of the Compositae family: Data of the Information Network of Departments of Dermatology (IVDK) from 2007 to 2016. Contact Dermatitis. 2019;80(4):222-7. |
| 106. | Worm M; Rak S; Samoli?ski B; Antila J; Höiby A.S; Kruse B; Lipiec A; Rudert M; Valovirta E (2019). Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension. Clin Exp Allergy. 49(4):516-25. |
| 107. | Bacher P; Hohnstein T; Beerbaum E; Röcker M; Blango MG; Kaufmann S; Röhmel J; Eschenhagen P; Grehn C; Seidel K; Rickerts V; Lozza L; Stervbo U; Nienen M; Babel N; Milleck J; Assenmacher M; Cornely OA; Ziegler M; Wisplinghoff H; Heine G; Worm M; Siegmund B; Maul J; Creutz P; Tabeling C; Ruwwe-Glösenkamp C; Sander LE; Knosalla C; Brunke S; Hube B; Kniemeyer O; Brakhage AA; Schwarz C; Scheffold A (2019). Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. Mar 7;176(6):1340-1355.e15. |
| 108. | Wittenberg M; Worm M (2019). Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab. Front Med (Lausanne). 6:8. |
| 109. | Claßen A; Buhl T; Schubert S; Worm M; Bauer A; Geier J; Molin S; Information Network of Departments of Dermatology (IVDK) study group (2019). The frequency of specific contact allergies is reduced in patients with psoriasis. Brit J Dermatol. 2019;180(2):315-20. |
| 110. | Töröcsik D; Weise C; Gericke J; Szegedi A; Lucas R; Mihaly J; Worm M; Rühl, R (2019). Transcriptomic and lipidomic profiling of eicosanoid/docosanoid signalling in affected and non-affected skin of human atopic dermatitis patients. Exp Dermatol. 28(2):177-89. |
| 111. | Francuzik W; Geier J; Schubert S; Worm M (2019). A case-control analysis of skin contact allergy in children and adolescents. Pediatr Allergy Immunol. Sep;30(6):632-637. |
| 112. | Tanno LK; Chalmers R; Bierrenbach AL; Simons FER; Martin B; Molinari N; Annesi-Maesano I; Worm M; Cardona V; Papadopoulos NG; Sanchez-Borges M; Rosenwasser LJ; Ansontegui I; Ebisawa M; Sisul JC; Jares E; Gomez M; Agache I; Hellings P; Muraro A; Thien F; Pawankar R; Sublett JL; Casale T; Demoly P; Joint Allergy Academies (2019). Changing the history of anaphylaxis mortality statistics through the World Health Organization’s International Classification of Diseases-11. J Allergy Clin Immunol. Sep;144(3):627-633. |
| 113. | Süß H; Dölle-Bierke S; Geier J; Kreft B; Oppel E; Pföhler C; Skudlik C; Worm M; Mahler V (2019). Contact urticaria: Frequency, elicitors and cofactors in three cohorts (Information Network of Departments of Dermatology; Network of Anaphylaxis; and Department of Dermatology, University Hospital Erlangen, Germany). Contact Dermatitis. Nov;81(5):341-353. |
| 114. | Dölle-Bierke S; Siebenhaar F; Burmeister T; Worm M (2019). Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase-first data from the Anaphylaxis Registry (NORA). Allergy Clin Immunol. Nov;144(5):1448-1450.e1. |
| 115. | Krishna MT; Worm M; Bilo MB (2019). Editorial: Anaphylaxis – A Distinct Immunological Syndrome, but How Much Do We Really Understand? Front Immunol. Dec 19;10:2943. |
| 116. | Worm M; Simpson EL; Thaçi D; Bissonnette R; Lacour JP; Beissert S; Kawashima M; Ferrándiz C; Smith CH; Beck LA; Chan KC; Chen Z; Akinlade B; Hultsch T; Staudinger H; Gadkari A; Eckert L; Davis JD; Rajadhyaksha M; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Ardeleanu M (2019). Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. Dec 26;156(2):131-43. |
| 117. | Eiwegger T; Anagnostou K; Arasi S; Bégin P; Ben-Shoshan M; Beyer K; Blumchen K; Brough H; Caubet JC; Chan ES; Chinthrajah S; Davis CM; Roches AD; Du Toit G; Elizur A; Galli SJ; Håland G; Hoffmann Sommergruber K; Kim H; Leung DYM; Muraro A; Nurmatov UB; Pajno GB; Sindher S; Szepfalusi Z; Torres MJ; Upton J; Worm M; Nadeau K (2019). ICER report for peanut OIT comes up short. Ann Allergy Asthma Immunol. 2019 Nov;123(5):430-432. |
| 118. | Blauvelt A; Rosmarin D; Bieber T; Simpson E L; Bagel J; Worm M; Deleuran M; Katoh N; Kawashima M; Shumel B; Chen Z; Rossi A B; Hultsch T; Ardeleanu M (2019). Improvement of Atopic Dermatitis With Dupilumab Occurs Equally Well Across Different Anatomical Regions: Data From Phase III Clinical Trials. Br J Dermatol. Jul;181(1):196-197. |
| 119. | Aparicio-Soto M; Redhu D; Sánchez-Hidalgo M; Fernández-Bolaños JG; Alarcón-de-la-Lastra C; Worm M; Babina M (2019).Olive-Oil-Derived Polyphenols Effectively Attenuate Inflammatory Responses of Human Keratinocytes by Interfering with the NF-?B Pathway. Mol Nutr Food Res. Nov;63(21):e1900019. |
| 120. | Russlies J; Fähnrich A; Witte M; Yin J; Benoit S; Gläser R; Günter C; Eming R; Erdmann J; Gola D; Gupta Y; Holtsche MM; Kern JS; König IR; Kiritsi D; Lieb W; Sadik CD; Sárdy M; Schauer F; van Beek N; Weidinger A; Worm M; Zillikens D; Schmidt E;, Busch H; Ibrahim SM; Hirose M (2019). Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans. Front Immunol. Nov 22;10:2200. |
| 121. | Gaziel Yablowitz M; Dölle S; Schwartz DG; Worm M (2019). Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study. JMIR Mhealth Uhealth. 2019 Aug 22;7(8):e13414. |
| 122. | Wagenmann M; Worm M; Akboga Y; Karjalainen M; Hohlfeld JM (2019). Randomized Immunotherapy Trial in Dual-Allergic Patients Using „Active Allergen Placebo“ as Control. Allergy. 2019 Aug;74(8):1480-1489. |
| 123. | Francuzik W; Dölle-Bierke S; Knop M; Scherer Hofmeier K; Cichocka-Jarosz E; García BE; Lang R; Maris I; Renaudin JM; Worm M (2019). Refractory Anaphylaxis: Data From the European Anaphylaxis Registry. Front Immunol. 2019 Oct 18;10:2482. |
| 124. | Grabenhenrich LB; Fernández-Rivas M; Dölle-Bierke S; Worm M (2019). Repeated epinephrine doses: An analysis of the European Anaphylaxis Registry, 2007-2018. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2935-2937. |
| 125. | Mahler V; Nast A; Bauer A; Becker D; Brasch J; Breuer K; Dickel H; Drexler H; Elsner P; Geier J; John SM; Kreft B; Köllner A; Merk H; Ott H; Pleschka S; Portisch M; Spornraft-Ragaller P; Weisshaar E; Werfel T; Worm M; Schnuch A; Uter W (2019). S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1. J Dtsch Dermatol Ges. 2019 Oct;17(10):1076-1093. |
| 126. | Mahler V; Nast A; Bauer A; Becker D; Brasch J; Breuer K; Dickel H; Drexler H; Elsner P; Geier J; John SM; Kreft B; Köllner A; Merk H; Ott H; Pleschka S; Portisch M; Spornraft-Ragaller P; Weisshaar E; Werfel T; Worm M; Schnuch A; Uter W (2019). S3 Guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 2. J Dtsch Dermatol Ges. 2019 Nov;17(11):1187-1207. |
| 127. | Hazzan T; Eberle J; Worm M; Babina M (2019). Thymic Stromal Lymphopoietin Interferes with the Apoptosis of Human Skin Mast Cells by a Dual Strategy Involving STAT5/Mcl-1 and JNK/Bcl-xL. Cells. 2019 Aug 5;8(8):829. |
| 128. | Turner PJ; Worm M; Ansotegui IJ; El-Gamal Y; Rivas MF; Fineman S; Geller M; Gonzalez-Estrada A; Greenberger PA; Tanno LK; Borges MS; Senna G; Sheikh A; Thong BY; Ebisawa M; Cardona V; WAO Anaphylaxis Committee (2019). Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J. 2019 Oct 31;12(10):100066. |
| 129. | Eiwegger T; Anagnostou K; Arasi S; Bégin P; Ben-Shoshan M; Beyer K; Blumchen K; Brough H; Caubet JC; Chan ES; Chen M; Chinthrajah S; Davis CM; Des Roches A; Du Toit G; Elizur A; Galli SJ; Håland G; Hoffmann-Sommergruber K; Kim H; Leung DYM; Long A; Muraro A; Nurmatov UB; Pajno GB; Sampath V; Saxena J; Sindher S; Upton J; Worm M; Nadeau KC (2020). Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here? J Allergy Clin Immunol. 2020 Apr;145(4):1153-1156. |
| 130. | Worm M; Bauer A; Elsner P; Mahler V; Molin S; Nielsen T S S (2020).Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study. Br J Dermatol. May;182(5):1103-1110. |
| 131. | Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N (2020). Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication. J Rheumatol. Feb;47(2):241-248. |
| 132. | Kraft M; Knop MP; Renaudin JM; Scherer Hofmeier K; Pföhler C; Bilò MB; Lang R; Treudler R; Wagner N; Spindler T; Hourihane JO; Maris I; Koehli A; Bauer A; Lange L; Müller S; Papadopoulos NG; Wedi B; Moeser A; Ensina LF; Fernandez-Rivas M; Cichocka-Jarosz E; Christoff G; Garcia BE; Poziomkowska-G?sicka I; Cardona V; Mustakov TB; Rabe U; Mahler V; Grabenhenrich L; Dölle-Bierke S; Worm M; Network for Online Registration of Anaphylaxis (NORA) (2020). Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry. Allergy. Apr;75(4):901-910. |
| 133. | Schnuch A; Schubert S; Lessmann H; Geier J; IVDK (2020). The methylisothiazolinone epidemic goes along with changing patients‘ characteristics – After cosmetics, industrial applications are the focus. Contact Dermatitis. Feb;82(2):87-93. |
| 134. | Matricardi PM; Dramburg S; Alvarez-Perea A; Antolín-Amérigo D; Apfelbacher C; Atanaskovic-Markovic M; Berger U; Blaiss MS; Blank S; Boni E; Bonini M; Bousquet J; Brockow K; Buters J; Cardona V; Caubet JC; Cavkaytar Ö; Elliott T; Esteban-Gorgojo I; Fonseca JA; Gardner J; Gevaert P; Ghiordanescu I; Hellings P; Hoffmann-Sommergruber K; Fusun Kalpaklioglu A; Marmouz F; Meijide Calderón Á; Mösges R; Nakonechna A; Ollert M; Oteros J; Pajno G; Panaitescu C; Perez-Formigo D; Pfaar O; Pitsios C; Rudenko M; Ryan D; Sánchez-García S; Shih J; Tripodi S; Van der Poel LA; van Os-Medendorp H; Varricchi G; Wittmann J; Worm M; Agache I. The role of mobile health technologies in allergy care: An EAACI position paper. Allergy. Feb;75(2):259-272. |
| 135. | Redhu D; Franke K; Kumari V; Francuzik W; Babina M; Worm M (2020). Thymic stromal lymphopoietin production induced by skin irritation results from concomitant activation of protease-activated receptor 2 and interleukin 1 pathways. Br J Dermatol. Jan;182(1):119-129. |
| 136. | Morand EF; Furie R; Tanaka Y; Bruce IN; Askanase AD; Richez C; Bae SC; Brohawn PZ; Pineda L; Berglind A; Tummala R; TULIP-2 Trial Investigators (2020). Trial of Anifrolumab in Active Systemic Lupus Erythematosus. N Engl J Med. Jan 16;382(3):211-221. |
| 137. | Heratizadeh A; Haufe E; Stölzl D; Abraham S; Heinrich L; Kleinheinz A; Wollenberg A; Weisshaar E; Augustin M; Wiemers F; Zink A; von Kiedrowski R; Hilgers M; Worm M; Pawlak M; Sticherling M; Fell I; Handrick C; Schäkel K; Staubach-Renz P; Asmussen A; Schwarz B; Bell M; Effendy I; Bieber T; Homey B; Gerlach B; Tchitcherina E; Stahl M; Schwichtenberg U; Rossbacher J; Buck P; Mempel M; Beissert S; Biedermann T; Weidinger S; Schmitt J; Werfel T; TREATgermany Study Group (2020).Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany. J Eur Acad Dermatol Venereol. Jun;34(6):1263-1272. |
| 138. | Rastogi S; Willmes DM; Nassiri M; Babina M; Worm M (2020). PGE 2 deficiency predisposes to anaphylaxis by causing mast cell hyperresponsiveness. J Allergy Clin Immunol. May 11;S0091-6749(20)30639-4. |
| 139. | Belz D; Moinzadeh P; Riemekasten G; Henes J; Müller-Ladner U; Blank N; Koetter I; Siegert E; Pfeiffer C; Schmalzing M; Zeidler G; Schmeiser T; Worm M; Guenther C; Susok L; Kreuter A; Sunderkoetter C; Juche A; Aberer E; Gaebelein-Wissing N; Ramming A; Kuhr K; Hunzelmann N (2020). Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic Sclerosis. Arthritis Care Res.;72(8):1041-1048. |
| 140., 141. | Kraft M; Scherer Hofmeier K; Ruëff F; Pföhler C; Renaudin JM; Bilò MB; Treudler R; Lang R; Cichocka-Jarosz E; Fernandez-Rivas M; Christoff G; Papadopoulos NG; Ensina L.F; Hourihane JO; Maris I; Koehli A; García BE; Jappe U; Vogelberg C; Ott H; Lange L; Spindler T; Dölle-Bierke S; Worm M (2020). Risk Factors and Characteristics of Biphasic Anaphylaxis. J Allergy Clin Immunol Pract. Nov-Dec;8(10):3388-3395.e6. |
| 142. | Buhl T; Beissert S; Gaffal E; Goebeler M; Hertl M; Mauch C; Reich K; Schmidt E; Schön MP; Sticherling M; Sunderkötter C; Traidl-Hoffmann C; Werfel T; Wilsman-Theis D; Worm M (2020). COVID-19 and implications for dermatological and allergological diseases. J Dtsch Dermatol Ges.18(8):815-824. |
| 143. | Juche A; Siegert E; Mueller-Ladner U; Riemekasten G; Günther C; Kötter I; Henes J; Blank N; Voll RE; Ehrchen J; Schmalzing M; Susok L; Schmeiser T; Sunderkoetter C; Distler J; Worm M; Kreuter A; Horváth ON; Schön MP; Korsten P; Zeidler G; Pfeiffer C; Krieg T; Hunzelmann N; Moinzadeh P (2020). |
| 144. | [Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]. |
| 145. | Z Rheumatol. 79(10):1057-1066. |
| 146. | Moinzadeh P; Kuhr K; Siegert E; Mueller-Ladner U; Riemekasten G; Günther C; Kötter I; Henes J; Blank N; Zeidler G; Pfeiffer C; Juche A; Jandova I; Ehrchen J; Schmalzing M; Susok L; Schmeiser T; Sunderkoetter C; Distler JHW; Worm M; Kreuter A; Krieg T; Hunzelmann N; Registry of the German Network for Systemic Scleroderma (2020). Older age onset of systemic sclerosis – accelerated disease progression in all disease subsets. Rheumatology. 59(11):3380-3389. |
| 147. | Pfaar O; Klimek L; Worm M; Bergmann KC; Bieber T; Buhl R; Buters J; Darsow U; Keil T; Kleine-Tebbe J; Lau S; Maurer M; Merk H; Mösges R; Saloga J; Staubach P; Stute P; Rabe K; Rabe U; Vogelmeier C; Biedermann T; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Tomazic PV; Aberer W; Fink-Wagner A; Horak F; Wöhrl S; Niederberger-Leppin V; Pali-Schöll I; Pohl W; Roller-Wirnsberger R; Spranger O; Valenta R; Akdis M; Akdis C; Hoffmann-Sommergruber K; Jutel M; Matricardi P; Spertini F; Khaltaev N; Michel JP; Nicod L; Schmid-Grendelmeier P; Hamelmann E; Jakob T; Werfel T; Wagenmann M; Taube C; Gerstlauer M; Vogelberg C; Bousquet J; Zuberbier T (2020). [Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. Laryngo Rhino Otol. 2020;99(10):676-679. |
| 148. | Klimek L; Pfaar O; Worm M; Bergmann KC; Bieber T; Buhl R; Buters J; Darsow U; Keil T; Kleine-Tebbe J; Lau S; Maurer M; Merk H; Mösges R; Saloga J; Staubach P; Stute P; Rabe K; Rabe U; Vogelmeier C; Biedermann T; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Tomazic P-V; Aberer W; Fink-Wagner A; Horak F; Wöhrl S; Niederberger-Leppin V; Pali-Schöll I; Pohl W; Roller-Wirnsberger R; Spranger O; Valenta R; Akdis M; Akdis C; Hoffmann-Sommergruber K; Jutel M; Matricardi P; Spertin F; Khaltaev N; Michel J-P; Nicod L; Schmid-Grendelmeier P; Hamelmann E; Jakob T; Werfel T; Wagenmann M; Taube C; Gerstlauer M; Vogelberg C; Bousquet J; Zuberbier T (2020). Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA GroupA in cooperation with the Austrian ARIA GroupB, the Swiss ARIA GroupC, German Society for Applied Allergology (AEDA)D, German Society for Allergology and Clinical Immunology (DGAKI)E, Society for Pediatric Allergology (GPA)F in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHCG and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol Select. May 28;4:44-52. |
| 149. | Klimek L; Pfaar O; Worm M; Bergmann KC; Bieber T; Buhl R; Buters J; Darsow U; Keil T; Kleine-Tebbe J; Lau S; Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Poethig D; Rabe K; Rabe U; Vogelmeier C; Biedermann T; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Tomazic PV; Aberer W; Fink-Wagner A; Horak F; Wöhrl S; Niederberger-Leppin V; Pali-Schöll I; Pohl W; Roller-Wirnsberger R; Spranger O; Valenta R; Akdis M; Akdis C; Hoffmann-Sommergruber K; Jutel M; Matricardi P; Spertini F; Khaltaev N; Michel JP; Nicod L; Schmid-Grendelmeier P; Hamelmann E; Jakob T; Werfel T; Wagenmann M; Taube C; Bousquet J; Zuberbier T; Vogelberg C; Gerstlauer M (2020). Allergen-Immuntherapie in der aktuellen Covid-19-Pandemie a, b, c Allergo J. 29(3):17-25. |
| 150. | Worm M (2020). Anaphylaxien nach Arzneimittelgabe. Drug Res (Stuggg). Nov;70(S 01):S12. |
| 151. | Klimek L; Pfaar O; Worm M; Eiwegger T; Hagemann J; Ollert M; Untersmayr E; Hoffmann-Sommergruber K; Vultaggio A; Agache I; Bavbek S; Bossios A; Casper I; Chan S; Chatzipetrou A; Vogelberg C; Firinu D; Kauppi P; Kolios A; Kothari A; Matucci A; Palomares O; Szépfalusi Z; Pohl W; Hötzenecker W; Rosenkranz A; Bergmann K-C; Bieber T; Buhl R; Buters J; Darsow U; Keil T; Kleine-Tebbe J; Lau S; Maurer M; Merk H; Mösges R; Saloga J; Staubach P; Jappe U; Rabe C; Rabe U; Vogelmeier C; Biedermann T; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Freudelsperger L; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Tomazic P-V; Aberer W; Fink W A; Horak F; Wöhrl S; Niederberger-Leppin V; Pali-Schöll I; Roller-Wirnsberger R; Spranger O; Valenta R; Akdis M; Matricardi P M; Spertini F; Khaltaev N; Michel J-P; Nicod L; Schmid-Grendelmeier P; Idzko M; Hamelmann E; Jakob T; Werfel T; Wagenmann M; Taube C; Jensen-Jarolim E; Korn S; Hentges F; Schwarze J; O Mahony L; Knol E; Del Giacco S; Chivato T; Bousquet J; Zuberbier T; Akdis C; Jutel M (2020). Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemie a, b, c: Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)D, der Luxemburgischen Gesellschaft für Allergologie und Immunologie (LGAI)E, der Österreichischen Gesellschaft für Pneumologie (ÖGP)F in Kooperation mit der deutschen, österreichischen, und schweizerischen ARIA-GruppeG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H. Allergo J. 29(4):14-27. |
| 152. | Aparicio-Soto M; Riedel F; Leddermann M; Bacher P; Scheffold A; Kuhl H; Timmermann B; Chudakov DM; Molin S; Worm M; Heine G; Thierse HJ; Luch A; Siewert K (2020). TCRs with segment TRAV9-2 or a CDR3 histidine are overrepresented among nickel-specific CD4+ T cells. Allergy. 2020 Oct;75(10):2574-2586. |
| 153. | Buhl T; Beissert S; Gaffal E; Goebeler M; Hertl M; Mauch C; Reich K; Schmidt E; Schön MP; Sticherling M; Sunderkötter C; Traidl-Hoffmann C; Werfel T; Wilsman-Theis D; Worm M (2020). COVID?19 und Auswirkungen auf dermatologische und allergologische Erkrankungen. J Dtsch Dermatol Ges. 2020 Aug;18(8):815-825. German. |
| 154. | Cardona V; Ansotegui IJ; Ebisawa M; El-Gamal Y; Fernandez Rivas M; Fineman S; Geller M; Gonzalez-Estrada A; Greenberger PA; Sanchez Borges M; Senna G; Sheikh A; Tanno LK; Thong BY; Turner P; Worm M (2020). World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020 Oct 30;13(10):100472. |
| 155. | de Silva D; Roberts G; Worm M; Muraro A; EAACI Food Allergy and Anaphylaxis Guidelines Group (2020). EAACI anaphylaxis guidelines: systematic review protocol. Clin Transl Allergy. 2020 May 20;10:14. |
| 156. | Dickel H; Kuhlmann L; Bauer A; Bircher AJ; Breuer K; Fuchs T; Grabbe J; Mahler V; Pföhler C; Przybilla B; Rieker-Schwienbacher J; Schröder-Kraft C; Simon D; Treudler R; Weisshaar E; Worm M; Trinder E; Geier J (2020). Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000-2015: a retrospective multicentre study. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):2086-2095. |
| 157. | Klimek L; Pfaar O; Worm M; Eiwegger T; Hagemann J; Ollert M; Untersmayr E; Hoffmann-Sommergruber K; Vultaggio A; Agache I; Bavbek S; Bossios A; Casper I; Chan S; Chatzipetrou A; Vogelberg C; Firinu D; Kauppi P; Kolios A; Kothari A; Matucci A; Palomares O; Szépfalusi Z; Pohl W; Hötzenecker W; Rosenkranz AR; Bergmann KC; Bieber T; Buhl R; Buters J; Darsow U; Keil T; Kleine-Tebbe J; Lau S; Maurer M; Merk H; Mösges R; Saloga J; Staubach P; Jappe U; Rabe KF; Rabe U; Vogelmeier C; Biedermann T; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Freudelsperger L; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Tomazic PV; Aberer W; Fink-Wagner AH; Horak F; Wöhrl S; Niederberger-Leppin V; Pali-Schöll I; Pohl W; Roller-Wirnsberger R; Spranger O; Valenta R; Akdis M; Matricardi PM; Spertini F; Khaltaev N; Michel JP; Nicod L; Schmid-Grendelmeier P; Idzko M; Hamelmann E; Jakob T; Werfel T; Wagenmann M; Taube C; Jensen-Jarolim E; Korn S; Hentges F; Schwarze J; O Mahony L; Knol EF; Del Giacco S; Chivato Pérez T; Bousquet J; Bedbrook A; Zuberbier T; Akdis C; Jutel M (2020). Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol Select. 2020 Sep 7;4:53-68. |
| 158. | Klimek L; Worm M; Lange L; Beyer K; Rietschel E; Vogelberg C; Schnadt S; Stöcker B; Brockow K; Hagemann J; Bieber T; Wehrmann W; Becker S; Freudelsperger L; Mülleneisen NK; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Dramburg S; Matricardi P; Hamelmann E; Werfel T; Wagenmann M; Taube C; Zuberbier T; Ring J. Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie: Ein Positionspapier des Ärzteverbandes Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C und des Deutschen Allergie- und Asthmabundes (DAAB)D (2020). Allergo J. 2020;29(7):16-26. German. |
| 159. | Kraft M; Dölle-Bierke S; Turner PJ; Muraro A; Fernández-Rivas M; Grabenhenrich L; Worm M (2020). EAACI Task force Clinical epidemiology of anaphylaxis: experts‘ perspective on the use of adrenaline autoinjectors in Europe. Clin Transl Allergy. 2020 May 11;10:12. |
| 160. | Scarpone R; Francuzik W; Worm M; Heine G (2020). Therapy Changes During Pemphigus Management: A Retrospective Analysis. Front Med (Lausanne). 2020 Nov 25;7:581820. |
| 161. | Scarpone R; Meier K; Ghoreschi K; Worm M (2020). Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses. Acta Derm Venereol. 2020 Oct 21;100(17):adv00298. |
| 162. | Scarpone R; Oestmann E; Kraft M; Worm M (2020). Good tolerability when switching from an aqueous ultra-rush Hymenoptera venom immunotherapy to a depot preparation. Allergy. 2020 Jul;75(7):1800-1802. |
| 163. | Schmidt E; Sticherling M; Sárdy M; Eming R; Goebeler M; Hertl M; Hofmann SC; Hunzelmann N; Kern JS; Kramer H; Nast A; Orzechowski HD; Pfeiffer C; Schuster V; Sitaru C; Zidane M; Zillikens D; Worm M (2020). S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update. J Dtsch Dermatol Ges. 2020 May;18(5):516-527. German. |
| 164. | Schmidt E; Sticherling M; Sárdy M; Eming R; Goebeler M; Hertl M; Hofmann SC; Hunzelmann N; Kern JS; Kramer H; Nast A; Orzechowski HD; Pfeiffer C; Schuster V; Sitaru C; Zidane M; Zillikens D; Worm M (2020). S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update. J Dtsch Dermatol Ges. 2020 May;18(5):516-526. |
| 165. | Schnuch A; Schubert S; Lessmann H; Geier J; IVDK (2020). The methylisothiazolinone epidemic goes along with changing patients‘ characteristics – After cosmetics, industrial applications are the focus. Contact Dermatitis. 2020 Feb;82(2):87-93. |
| 166. | Seegräber M; Worm M; Werfel T; Svensson A; Novak N; Simon D; Darsow U; Augustin M; Wollenberg A (2020). Recurrent eczema herpeticum – a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients. J Eur Acad Dermatol Venereol. 2020 May;34(5):1074-1079. |
| 167. | Worm M; Ballmer-Weber B; Brehler R; Cuevas M; Gschwend A; Hartmann K; Hawranek T; Hötzenecker W; Homey B; Jakob T; Novak N; Pickert J; Saloga J; Schäkel K; Trautmann A; Treudler R; Wedi B; Sturm G; Rueff F (2020). Versorgungssituation von Insektengiftallergikern während der COVID-19-Pandemie. Allergo J. 2020;29(8):16-21. German. |
| 168. | Worm M; Ballmer-Weber B; Brehler R; Cuevas M; Gschwend A; Hartmann K; Hawranek T; Hötzenecker W; Homey B; Jakob T; Novak N; Pickert J; Saloga J; Schäkel K; Trautmann A; Treudler R; Wedi B; Sturm G; Rueff F (2020). Healthcare provision for insect venom allergy patients during the COVID-19 pandemic. Allergo J Int. 2020;29(8):257-261. |
| 169. | Worm M; Francuzik W; Kraft M; Alexiou A (2020). Moderne Therapie der atopischen Dermatitis: Biologika und kleinmolekulare Medikamente. J Dtsch Dermatol Ges. 2020 Oct;18(10):1085-1093. German. |
| 170. | Worm M; Francuzik W; Kraft M; Alexiou A (2020). Modern therapies in atopic dermatitis: biologics and small molecule drugs. J Dtsch Dermatol Ges. 2020 Oct;18(10):1085-1092. |
| 171. | Worm M; Nguyen D; Rackley R; Muraro A; Du Toit G; Lawrence T; Li H; Brumbaugh K; Wickman M (2020). Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances. Clin Transl Allergy. 2020 Jun 10;10:21. |
| 172. | Wurpts G; Aberer W; Dickel H; Brehler R; Jakob T; Kreft B; Mahler V; Merk HF; Mülleneisen N; Ott H; Pfützner W; Röseler S; Ruëff F; Sitter H; Sunderkötter C; Trautmann A; Treudler R; Wedi B; Worm M; Brockow K (2020). Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Society of Allergology (AeDA), German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Austrian Society for Allergology and Immunology (ÖGAI), and the Paul-Ehrlich Society for Chemotherapy (PEG). Allergol Select. 2020 May 28;4:11-43. |